These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 17550324)

  • 1. Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia.
    Manthawornsiri Y; Polpanich D; Yamkamon V; Thiramanas R; Hongeng S; Rerkamnuaychoke B; Jootar S; Tangboriboonrat P; Jangpatarapongsa K
    J Clin Lab Anal; 2016 Sep; 30(5):534-42. PubMed ID: 26667895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations.
    Zhang T; Grenier S; Nwachukwu B; Wei C; Lipton JH; Kamel-Reid S;
    J Mol Diagn; 2007 Sep; 9(4):421-30. PubMed ID: 17690211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia.
    Wei W; Li S; Zhang Y; Deng S; He Q; Zhao X; Xu Y; Yu L; Ye J; Zhao W; Jiang Z
    Lab Chip; 2024 Jun; 24(12):3080-3092. PubMed ID: 38747247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.
    Branford S; Fletcher L; Cross NC; Müller MC; Hochhaus A; Kim DW; Radich JP; Saglio G; Pane F; Kamel-Reid S; Wang YL; Press RD; Lynch K; Rudzki Z; Goldman JM; Hughes T
    Blood; 2008 Oct; 112(8):3330-8. PubMed ID: 18684859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL gene variants.
    Melo JV
    Baillieres Clin Haematol; 1997 Jun; 10(2):203-22. PubMed ID: 9376660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries.
    Valvert F; Silva O; Solórzano-Ortiz E; Puligandla M; Siliézar Tala MM; Guyon T; Dixon SL; López N; López F; Carías Alvarado CC; Terbrueggen R; Stevenson KE; Natkunam Y; Weinstock DM; Briercheck EL
    Blood Adv; 2021 May; 5(10):2447-2455. PubMed ID: 33988700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances.
    Cumbo C; Anelli L; Specchia G; Albano F
    Cancer Manag Res; 2020; 12():3175-3189. PubMed ID: 32440215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.
    Alikian M; Gale RP; Apperley JF; Foroni L
    Biomol Detect Quantif; 2017 Mar; 11():4-20. PubMed ID: 28331814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.
    García-Gutiérrez V; Gómez-Casares MT; Puerta JM; Alonso-Domínguez JM; Osorio S; Hernández-Boluda JC; Collado R; Ramírez MJ; Ibáñez F; Martín ML; Rodríguez-Gambarte JD; Martínez-Laperche C; Gómez M; Fiallo DV; Redondo S; Rodríguez A; Ruiz-Nuño C; Steegmann JL; Jiménez-Velasco A;
    PLoS One; 2017; 12(3):e0173532. PubMed ID: 28278193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
    Al-Dewik NI; Morsi HM; Samara MM; Ghasoub RS; Gnanam CC; Bhaskaran SK; Nashwan AJ; Al-Jurf RM; Ismail MA; AlSharshani MM; AlSayab AA; Ben-Omran TI; Khatib RB; Yassin MA
    Clin Med Insights Oncol; 2016; 10():95-104. PubMed ID: 27721664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current developments in molecular monitoring in chronic myeloid leukemia.
    Marum JE; Branford S
    Ther Adv Hematol; 2016 Oct; 7(5):237-251. PubMed ID: 27695615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
    Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB
    Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an integrated assay for detection of BCR-ABL RNA.
    Winn-Deen ES; Helton B; Van Atta R; Wong W; Peralta J; Wang J; Tsongalis GJ; Belloni D; Chan D; Eshleman JR; Gocke CD; Jobbagy Z; Beppu L; Radich JP
    Clin Chem; 2007 Sep; 53(9):1593-600. PubMed ID: 17660274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia.
    Hessner MJ; Roth MS; Drobyski WR; Baxter-Lowe LA
    Genet Anal Tech Appl; 1994; 11(4):90-4. PubMed ID: 7857690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular monitoring.
    Soverini S; Rosti G; Baccarani M; Martinelli G
    Curr Hematol Malig Rep; 2014 Mar; 9(1):1-8. PubMed ID: 24395452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of the BCR-ABL transcript using the Cepheid Xpert BCR-ABL Monitor assay.
    Dufresne SD; Belloni DR; Levy NB; Tsongalis GJ
    Arch Pathol Lab Med; 2007 Jun; 131(6):947-50. PubMed ID: 17550324
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.